Review
doi: 10.1586/eri.13.14.
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management
Affiliations
- PMID: 23566148
- DOI: 10.1586/eri.13.14
Item in Clipboard
Review
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management
Expert Rev Anti Infect Ther.
2013 Apr.
Abstract
Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A. baumannii are on the rise and are slowly becoming a routine phenotype for this organism. This review focuses on infection control strategies for identification and control of A. baumannii, as well the available therapeutic options.
Similar articles
-
Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies.Expert Rev Anti Infect Ther. 2013 Apr;11(4):395-409. doi: 10.1586/eri.13.21. Expert Rev Anti Infect Ther. 2013. PMID: 23566149 Review.
-
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.Microb Drug Resist. 2014 Aug;20(4):259-63. doi: 10.1089/mdr.2013.0127. Epub 2013 Dec 11. Microb Drug Resist. 2014. PMID: 24328852
-
Isolation of genetically indistinguishable carbapenem-resistant and -susceptible Acinetobacter baumannii isolates from a single patient.Antimicrob Agents Chemother. 2013 Nov;57(11):5781-2. doi: 10.1128/AAC.01631-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979743 Free PMC article. No abstract available.
-
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.Clin Lab. 2015;61(7):741-7. doi: 10.7754/clin.lab.2014.141116. Clin Lab. 2015. PMID: 26299073
-
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Expert Rev Anti Infect Ther. 2013 Jun;11(6):571-83. doi: 10.1586/eri.13.38. Expert Rev Anti Infect Ther. 2013. PMID: 23750729 Review.
Cited by
-
Comparative Genomics of Acinetobacter baumannii Clinical Strains From Brazil Reveals Polyclonal Dissemination and Selective Exchange of Mobile Genetic Elements Associated With Resistance Genes.Front Microbiol. 2020 Jun 17;11:1176. doi: 10.3389/fmicb.2020.01176. eCollection 2020. Front Microbiol. 2020. PMID: 32655514 Free PMC article.
-
Increased Antimicrobial Resistance among Sputum Pathogens from Patients with Hyperglycemia.Infect Drug Resist. 2020 Jun 11;13:1723-1733. doi: 10.2147/IDR.S243732. eCollection 2020. Infect Drug Resist. 2020. PMID: 32606822 Free PMC article.
-
Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures.Antibiotics (Basel). 2022 Aug 8;11(8):1076. doi: 10.3390/antibiotics11081076. Antibiotics (Basel). 2022. PMID: 36009945 Free PMC article.
-
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.Emerg Infect Dis. 2018 Apr;24(4):727-734. doi: 10.3201/eid2404.171461. Emerg Infect Dis. 2018. PMID: 29553339 Free PMC article.
-
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii.Antibiotics (Basel). 2021 Jul 20;10(7):880. doi: 10.3390/antibiotics10070880. Antibiotics (Basel). 2021. PMID: 34356801 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
